Bionano announces presentation of ogm utility across key research applications at the association for molecular pathology annual meeting

San diego, nov. 14, 2023 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced its participation in the association for molecular pathology (amp) 2023 annual meeting and expo with a broad range of content covering the utility of optical genome mapping (ogm) for cell and gene therapy and cancer research, including scientific workshops and poster presentations from bionano and researchers from across the genomics landscape.
BNGO Ratings Summary
BNGO Quant Ranking